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Abstract
Background: The key aim of the study is to establish an agreed standardised core outcome set (COS) for use when
evaluating non-pharmacological health and social care interventions for people living at home with dementia.
Methods/design: Drawing on the guidance and approaches of the Core Outcome Measures in Effectiveness Trials
(COMET), this study uses a four-phase mixed-methods design:
1 Focus groups and interviews with key stakeholder groups (people living with dementia, care partners, relevant
health and social care professionals, researchers and policymakers) and a review of the literature will be
undertaken to build a long list of outcomes.
2 Two rounds of Delphi surveys will be used with key stakeholder groups. Statements for the Delphi surveys
and participation processes will be developed and informed through substantial member involvement with
people living with dementia and care partners. A consensus meeting will be convened with key participant
groups to discuss the key findings and finalise the COS.
3 A systematic literature review will be undertaken to assess the properties of tools and instruments to assess
components of the COS. Measurement properties, validity and reliability will be assessed using the Consensus-
based Standards for the Selection of Health Measurement (COSMIN) and COMET guidance.
4 A stated preference survey will elicit the preferences of key stakeholders for the outcomes identified as
important to measure in the COS.
Discussion: To the best of our knowledge, this study is the first to use a modified Delphi process to involve people living
with dementia as a participant group. Though the study is confined to collecting data in the United Kingdom, use of the
COS by researchers will enhance the comparability of studies evaluating non-pharmacological and community-based
interventions.
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Background
It is currently estimated that there are 850,000 people
living with dementia in the UK, two-thirds of whom live
in their own homes. Being in a familiar neighbourhood
and family surroundings can help people living with de-
mentia cope better with their everyday lives and more-
over, the majority of people living with dementia want to
stay in their own home [1, 2].
One-third of people living with dementia live alone
and are particularly reliant on support from family
members, community services or home care agencies [1,
3]. In the UK, and in recent years, the range of non-
pharmacological support available to people living with
dementia to retain independence in their own homes
and neighbourhoods has increased [3, 4]. Consequently,
there is a growing demand for evidence-based care and
interventions that seek to improve the outcomes for
people living with dementia [5] with the corollary being
the identification of outcomes that are deemed import-
ant by key stakeholders.
In recent years, a limited consensus has been reached
about what outcomes should be measured in dementia ser-
vices and studies. For example, in 2007, the International
Psychogeriatric Association published a consensus state-
ment calling for clear predefined outcome measures when
assessing treatment benefits for dementia. The association
recommended that outcomes could include: the effect of
interventions on people living with dementia’s cognition,
behavioural and psychological symptoms; quality of life;
global assessments and activities of daily living. In addition,
it was recommended that outcomes could encompass the
effects on care partners [6].
With a focus on disease modification interventions in
people living with mild to moderate dementia, Webster
and colleagues [7] recommended that cognition (mea-
sured with the cognitive subscale of the Alzheimer’s
Disease Assessment Scale [8] or the Mini Mental State
Exam [9]) and biological markers (magnetic resonance
imaging [10]) should be the only core outcome domains.
Other recommendations were made for important, but
non-core, domains and included activities of daily living
(Disability Assessment for Dementia [11]), global func-
tioning (Clinical Dementia Rating [12]), neuropsychiatric
aspects (Neuropsychiatric Inventory [13]) and quality of
life (Dementia Quality of Life [14]).
Another study identified outcomes suitable when
examining the effect of psychosocial interventions in
dementia care. Using a consensus meeting approach, this
study identified 22 measures across nine conceptual do-
mains covering patient-based measures (mood, quality
of life, activities of daily living, instrumental activities of
daily living and behaviour), carer-based measures (mood,
quality of life and burden) and staff-based measures
(morale) [15].
Currently, the only ‘effective practice and health sys-
tems’ review registered with the Cochrane Dementia and
Cognitive Improvement Group is of case management
for people living with dementia [16]. The researchers in
this review used the following categorisation for synthe-
sising outcomes: avoidance of institutionalisation; num-
bers of admissions; quality of life/wellbeing; cognitive
functioning; neuropsychiatric/behavioural and psycho-
logical symptoms; mood; activities of daily living; and so-
cial engagement. This review and many completed and
ongoing Cochrane reviews of interventions for people
living with dementia face a high degree of variation in
outcome measures. Limited consistency between studies
can lead to marked heterogeneity and reporting biases
[16, 17], thus impeding comparison of findings across
studies and making meta-analyses and interpretation of
results difficult [18].
Furthermore, existing measures may not detect, or in-
clude, outcomes that are important and meaningful to
people with dementia, whose perspectives are often not
represented [19, 20]. More generally, although recent
evidence suggests patient or public involvement in iden-
tifying priorities and outcomes of importance is still an
emerging area [20], it is often not done [7, 15] or imple-
mented poorly [21]. Yet, studies that have done so have
identified outcomes that were not previously identified
by clinicians [22]. Given that nearly two-thirds of people
with dementia live at home, outcome measures in exist-
ing studies do not necessarily reflect the types of out-
comes these people seek from dementia care in
neighbourhood and community settings [23].
This study is a dedicated work programme (work
programme 3) of the Economic and Social Research
Council (ESRC) and National Institute for Health
Research (NIHR) Neighbourhoods and Dementia mixed-
methods research study (http://www.neighbourhoodsand-
dementia.org; henceforward, the Neighbourhoods and
Dementia study). The five-year Neighbourhoods and
Dementia study (2014–2019) is one of the studies being
funded under key commitment 12 of the first Prime
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Minister’s Challenge on dementia, a commitment of
funding for social science research, and explores the
meanings, experiences and composition of neighbour-
hoods for people living with dementia, their care
partners and families, and other groups and individ-
uals with whom they have contact [24].
Led by Professor John Keady (chief investigator) at the
Division of Nursing, Midwifery and Social Work (School
of Health Sciences, University of Manchester), the
Neighbourhoods and Dementia programme is framed
around people, spaces and places and aims to:
 Address the meanings, experiences and structure of
neighbourhoods for people living with dementia,
their care partners and other in-contact-groups and
individuals
 Learn from the process and praxis of making people
living with dementia and their care partners core to
the research agenda
 Encourage innovative technological advances in
dementia studies and in the development of a
neighbourhood model of dementia
 Build capacity within the research community and
the networks of people living with dementia and
their care partners
 Develop the evidence base, methods and measures
for understanding the significance of
neighbourhoods for people living with dementia and
their care partners
 Create, test and evaluate interventions that are
pertinent to a neighbourhood model of dementia
The central aim of work programme 3, led by Dr
Siobhan Reilly at the Division of Health Research (Fac-
ulty of Health & Medicine, Lancaster University) of the
Neighbourhoods and Dementia study is to develop a
core outcome set (COS) that can be used when evaluat-
ing non-pharmacological health and social care
community-based interventions for people living with
dementia at home and in their own neighbourhood lo-
cality. As such, the emphasis is on identifying outcomes
that are important to the person living with dementia.
The study will:
i) Identify and attain a consensus around which
outcomes should be measured from the perspective
of key stakeholders (people living at home with
dementia, care partners, health and social care
professionals, researchers and policymakers).
ii) Review and recommend how outcomes should be
measured.
Throughout this study, the five key stakeholders
groups are defined as:
1. People living with dementia: People either formally
or self-diagnosed with dementia and who live at
home.
2. Care partners1: People with current or past
experiences of providing care for a person living
with dementia.
3. Health and social care professionals: People
currently or recently employed by a public or
private organisation that provides care or support
in a health or social setting for people living with
dementia.
4. Researchers: People with current or recent
experience of undertaking dementia-related
research (i.e. as denoted by being a lead or co-author
on dementia-related peer-reviewed publications or
involvement in current dementia-related research).
5. Policymakers: People in a senior role with influence
to shape national, regional or local dementia policy
or who are able to commission dementia service
provision. This includes those who plan services.
There are additional inclusion criteria, and these are
outlined in the recruitment sections of the protocol.
Methods/design
There is no recognised gold standard for the develop-
ment of a COS. This study applies an approach that uses
guidance from the Core Outcome Measures in Effective-
ness Trials (COMET) and includes a four-phase mixed-
methods study design (Fig. 1).
Phase 1: Identification of potential outcomes through
qualitative data collection and a literature review
Phase 1.1: Interviews and focus groups
Note that it was necessary to complete phase 1 and the
early stages of phase 2 to inform the design of the
Delphi surveys. Thus, the sections on phase 1 and the
member involvement undertaken in relation to the
Delphi surveys in phase 2 describe what we have already
done. However, no substantive findings are presented in
this paper.
Focus groups and interviews were used to identify
which outcomes are important for people living at home
with dementia within each stakeholder group. Group
size and specific approaches depended on the stake-
holder group and approaches differed due to methodo-
logical and practical considerations, such as individual
capacity and preferences, and time pressure of care
professionals.
Focus groups have been found to be appropriate for
research involving people living with dementia [19, 25,
26]. There are a number of advantages to group discus-
sions. They can enhance the quality of interaction, re-
duce the pressure on individuals to respond, and provide
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mutual support and opportunities for shared experiences
to stimulate the memories of people living with demen-
tia [19].
In the study, people living with dementia who lacked
mental capacity and who had an identified personal con-
sultee were invited for an interview rather than a group
discussion. This provided an important opportunity to en-
able the researcher to build rapport with the person living
with dementia and to foster a good relationship [27].
Phase 1.1: Recruitment:
Recruitment of people living with dementia We re-
cruited a sample of people living with dementia who
met the following criteria:
Inclusion criteria:
 They had a diagnosis of dementia (self or
professional reported).
 They lived at home in the community in the north-
west of England.
 They had capacity to understand and consent to
participate in the study (including those who could
consent in the moment), or had a personal
consultee who was identified and approached if
individuals living with dementia were not able to
consent in the moment.
 They were able to converse in English.
Exclusion criteria:
 They were living in institutional care (nursing home,
care home, or hospital).
 They were too unwell to participate.
 They did not speak English.
 They did not have capacity to consent to participate
in the study and did not have a personal consultee,
or where a personal consultee was identified but
declined to give their agreement to approach the
person living with dementia.
To identify people living with dementia, we liaised
with relevant clinical research network staff at National
Health Service (NHS) trusts and staff within third-sector
organisations (e.g. Alzheimer’s Society and local memory
cafes) to identify potential participants.
Fig. 1 Study design of the development of a core outcome set for evaluating community health and social care interventions for people who
live at home with dementia
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Recruitment process for people living with dementia
Potential participants were given information about the
study and the opportunity to express an interest in tak-
ing part by returning an expression of interest reply slip.
If the person had capacity to consent, they returned the
reply slip themselves or to a member of staff (NHS or
third-sector organisation), who sent it on their behalf. If
the person did not have capacity to consent, the reply
slip was sent by a personal consultee. Those who
responded were contacted by the researcher via their
preferred method to discuss their participation.
Participants were asked to provide written consent.
On arrival for the focus group or interview, the partici-
pants (and care partners) were met by a member of the
research team, who went over information about the
study and how the focus group or interview was going
to run, and also went through the consent form with
them confirming they had understood the information.
They were given the opportunity to ask any questions
and to have these answered. At this stage, the people liv-
ing with dementia were asked to sign the consent form,
with provision for verbal, recorded consent for those
experiencing difficulty with writing. It was made clear
from the start that a decision to take part in the study
was entirely voluntary and that they could leave the
study without an impact upon any care they receive.
These processes provided adequate time to ensure that
participants did not feel rushed or unable to ask ques-
tions at this point in their involvement.
Recruitment of care partners We recruited a sample of
care partners who met the following criteria:
 They were self-reported care partners (family member
or friend) of a person with a diagnosis of dementia
who met the study inclusion criteria described earlier.
 They spoke English.
We identified and recruited care partners who met the
inclusion criteria using the following approaches:
 If their partner, a person living with dementia, had
been recruited to the study.
 Care partners were also recruited via NHS trust
clinics and third-sector organisations (Alzheimer’s
Society or local memory cafes).
Recruitment process for care partners Those care
partners who met the study inclusion criteria were given
information about the study and the opportunity to
express an interest in taking part. If interested, they
provided a preferred method of contact by returning an
expression of interest reply slip. Those who responded
were contacted by a researcher via their preferred
method to discuss their participation. A study informa-
tion sheet was given (either by post or in person by a re-
searcher), highlighting that a focus group would be
conducted with care partners for people living with de-
mentia to gain insight into their perspectives on out-
comes that are important for dementia care and services
in the community to support people living with demen-
tia at home. Care partners had opportunities to ask any
questions and to discuss any aspects of the study with
the researcher prior to their decision to participate. After
providing the study information sheet (leaving at least
24 h before further contact), a member of the research
team followed up potential participants to confirm their
willingness to take part in the study.
When people confirmed their interest in taking part,
invitations were sent to all participants seven days prior
to the focus group to confirm date, time, venue and ar-
rangements. Those who were not able to attend the
focus group were asked to notify the researcher, and al-
ternative arrangements made if they were still interested
in the study.
Written consent was obtained from those willing to
take part, before the focus group commenced and on
the same date as the group. On arrival for the focus
group, the participant was met by a member of the re-
search team, who went over information about the study
and how the focus group would proceed, and also went
through the consent form confirming that they under-
stood it. Any questions were answered. People were
asked to sign the consent form. A copy of the consent
form was stapled to the study information sheet and
given to participants for their records. It was made clear
from the start that their decision to take part in the
study was entirely voluntary.
Recruitment of health and social care professionals
and researchers Health and social care professionals
were recruited if they met the following criteria:
 Based in the UK and responsible for providing care
and treatment to people living with dementia and
their care partners, including general practitioners,
consultants, nursing staff, allied health professionals,
social care workers, and those who manage or run
social community-based programmes
 UK researchers involved in dementia intervention
studies involving people with dementia
Health and social care professionals and researchers
were recruited through the following methods:
 Through our co-applicants (e.g. colleagues who
lead and work on other work packages within the
Neighbourhoods and Dementia study), networks
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(e.g. Neighbourhoods and Dementia Study Advis-
ory Group and Scientific Advisory Groups, Aca-
demic Health Science Networks), study partners,
established contacts working in the NHS and so-
cial care services, and academic research
connections
Recruitment of policymakers At UK national, regional
and local levels, we approached and invited individuals
from organisations involved in implementing policy and
dementia care services, including clinical commissioners,
joint commissioners and clinical leads with clinical
commissioning groups, directors of public health, and
local authorities. These contacts and networks were de-
veloped and supported by our study advisory group, sci-
entific advisory group, clinical research network officers,
Neighbourhoods and Dementia study colleagues, and
academic research connections.
Recruitment process for health and social care
professionals, researchers and policymakers Potential
participants were contacted via their preferred contact
method as stated in the expression of interest slip, which
was attached to a cover letter and a study information
sheet. Upon receipt of acceptance, a mutually convenient
date was arranged for the interview or focus group. An in-
vitation letter was emailed to participants seven days prior
to the interview or focus group to confirm date, time,
venue and arrangements. All participants were asked to
provide written consent prior to their participation.
Data analysis
The focus groups and interviews were audiotaped, fully
transcribed verbatim, password protected and imported
into NVivo Version 11. We used NVivo to store, manage
and code all qualitative data. Full data analysis was not
required in this study phase as the purpose of these
qualitative data were for outcome identification. A cod-
ing framework was developed, drawn from qualitative
studies with people living with dementia and the review
of literature on existing outcomes reported as in studies
and reviews (phase 1.2). Outcomes and potential out-
come areas in the qualitative data were identified and
coded in the framework, which constituted an extracted
list of potential core outcomes [28]. All outcomes listed
as important by people living with dementia will be in-
cluded in the second phase of the study.
Phase 1.2: Literature review of existing outcomes reported
in studies and reviews
The Cochrane Dementia and Cognitive Improvement
Group of the Medical Sciences Division of Oxford Uni-
versity has created and manages a comprehensive and
open access register of dementia studies. This database,
known as the ALOIS database, is available online
(http://www.medicine.ox.ac.uk/alois/). The register con-
tains records of randomised controlled trials, controlled
clinical trials and some other open-label studies. The ad-
vanced search function allows users to search by study
aim, study design, intervention type or whether records
are Cochrane studies.
To locate outcomes used in existing studies, the ALOIS
database was searched for non-pharmacological interven-
tions. At the time of searching, there were nearly 5000 reg-
istered studies in the ALOIS database. Of these, 1009
studies were identified as non-pharmacological and 248
studies evaluated a community-based intervention. The ini-
tial extraction scoping exercise revealed some duplication
of outcomes across studies. Given the time constraints in-
volved in undertaking the parallel qualitative element of the
study (to ascertain outcomes important to key stakeholders,
including people living with dementia), extracting outcomes
from a sub-sample of the 248 studies was considered to be
adequate. Thus, primary and secondary outcomes were ex-
tracted from a random 50% sample (n = 124). However, to
be as exhaustive as possible, key reviews and qualitative
studies (n = 8) and policy documents (n = 38) were also
identified and outcomes extracted.
Phase 1.3: Bringing together the qualitative data and the
data extracted from the literature: developing the long list
Researcher and clinician workshops Outcomes ex-
tracted from phases 1.1 and 1.2 formed a long list of
outcomes. To form an accessible Delphi survey, the out-
comes needed to be grouped together where there were
areas of commonality or duplication and mapped into
outcome domains.
Reflecting previous work on COS development
using a Delphi approach, the research team held eight
meetings to remove areas of duplication, further con-
solidate areas of commonality and map outcomes in
domains [29]. Participants in these meetings were
from a range of health and social care research back-
grounds, and included those with both clinical and
caregiving experience.
Each meeting took between two and four hours and
involved a series of discussions and exercises. Adapted
from existing interactive focus group approaches [30,
31], every outcome was listed in a spreadsheet and
printed on individual pieces of paper. These individual
pieces of paper were placed onto a large table and were
positioned during the discussion according to partici-
pants’ views on the rationale for mapping outcomes into
domains, and merging or removing outcomes. Any dis-
agreements were resolved through discussion.
At the end of the eighth meeting, it was universally
agreed that this deliberative analysis was saturated.
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Phase 2: Delphi methodology
The Delphi method is a structured method for reaching
consensus, in which participants complete sequential
rounds of anonymised surveys. It is increasingly
regarded as a robust approach to gaining consensus
from different stakeholder groups [21]. This method,
modified to ensure the participation of people living
with dementia, will be used to reduce the range of items
down to a COS.
In this study, two rounds of surveys will be distributed
amongst each of the stakeholder groups. In round 1, par-
ticipants will rate each outcome. There will also be an
option for participants to add any additional outcomes
and to provide a score for each outcome added. Round 2
involves participants reviewing the round 1 scores of
other participant groups to reflect further on what is im-
portant. In round 2, participants will have the opportun-
ity to change their response.
Delphi design: role of member involvement
Each outcome will have an associated statement and
participants will be asked how important each statement
is. The initial statements were designed by members of
the research team. However, critical to the success of the
Delphi approach involving the participation of people
living with dementia is that research tools are accessible
and understandable [32].
Recent work has highlighted the desirability of and the
need to develop strategies and frameworks that consider
the views of stakeholders in COS design [21, 33, 34].
Referred to as member involvement, we have consulted
with people living with dementia and care partners to in-
form the design of COS research tools, including in the
design of and how to engage people living with dementia
appropriately in both rounds of the Delphi surveys. Indi-
viduals and groups who were involved in phase 1, and
from other Neighbourhoods and Dementia study work
programmes, were invited to consult. This was governed
by the same practices and ethical procedures as the
primary methods of data collection, and followed the
recommendations and guidance for appropriate, respect-
ful and safe inclusion of people living with dementia in
research [35–37]. Member involvement consultation
took place with three people living with dementia and
five groups.
Recruitment of people living with dementia and care partners
People living with dementia who have capacity and care
partners who participated in phase 1 will be approached
and invited to participate in the Delphi survey. If they are
interested in completing a Delphi survey, a researcher will
contact them through their preferred method to provide
information about the Delphi survey and to ensure that
they understand the survey and have the opportunity to
discuss any questions. Once they confirm their decision to
take part in the Delphi survey, participants will receive an
invitation to complete a researcher-supported survey or
postal survey (round 1) and researcher-supported survey
(round 2). A researcher-supported survey is where a re-
searcher supports the participation of a person living with
dementia in completing the survey, and is responsive to
the preferences of the individual.
Additional people living with dementia and care part-
ners who meet the study inclusion criteria will also be
recruited from a variety of settings, which may include
NHS trust clinics, primary care, third-sector organisa-
tions (e.g. Alzheimer’s Society) and the study website,
and also via the study’s social media outlets, public
engagement events within the local area and local news-
paper articles, and from the Join Dementia Research
register. We will recruit a sample of participants who
meet the same criteria as phase 1. A list of these poten-
tial participants will be collected and stored in a
password-protected database.
Those who meet the inclusion criteria will be given in-
formation about the Delphi survey and the opportunity
to express an interest in taking part in the study. If
potential participants are interested in the study, then
they, or a member of staff on their behalf, will provide a
preferred method of contact by returning an expression
of interest reply slip. Those who respond will then be
contacted by a researcher via their preferred method to
discuss their participation. Potential participants will
have the opportunity to ask any questions and discuss
any aspects of the Delphi study with the researcher
before making their decision.
Recruitment of health and social care professionals,
researchers and policymakers
Health and social care professionals, researchers and
policymakers participating in phase 1 will also be invited
to take part in the Delphi study. Additional health and
social care professionals, researchers and policymakers
will also be identified and recruited through contacts
and networks in the Neighbourhoods and Dementia
study work programme, the clinical research network,
social media, the study’s website, third-sector organisa-
tions and research networks (e.g. CHAIN; http://www.
chain-network.org.uk), and attendees and presenters at
relevant conferences and events.
Health and social care professionals, researchers and
policymakers will be contacted by email directly to
complete an online Delphi survey via an embedded link.
Reminder emails will be sent. The importance of com-
pleting both rounds of the Delphi exercise will be clearly
stated. If we find that particular groups are under-
represented, we will target these specifically.
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The Delphi survey scale
Although the Grading of Recommendations, Assessment,
Development and Evaluation scale outlines the desirability
of a nine-point scale (1–9) to rank the importance of each
outcome [38], one of the few existing Delphi studies that
did not make substantive modifications involving people
living with dementia indicates that even a scale with as
many as five points would be likely to be unsuccessful
[32]. Nor is it advisable to use a scale that accommodates
extremities and indicates that outcomes could be categor-
ically unimportant. An example of this is using ‘strongly
disagree’ (if written in the first person) or ‘not important’.
For people living with dementia, it is unlikely that out-
comes will categorically not be important [32]. It is prefer-
able to ask participants to consider which areas are of less
or greater importance, thus acknowledging that all out-
comes have some importance.
This study will use a three-point scale that will not
suggest categorical unimportance: (1) ‘not particularly
important’, (2) ‘important’ and (3) ‘very important’. This
three-point scale is a key modification to a regular
Delphi process, for which preliminary member involve-
ment has been received.
Delphi sample size
There is no consensus on the optimal sample size for a
Delphi study [22] and it is common practice to use prior
studies as an indicator of an appropriate sample size [39].
A recent review of Delphi COS studies suggests that the
average number of participants for mixed-participant
Delphi surveys such as this is 171 [21]. This Delphi survey
will aim to purposively recruit approximately 200 partici-
pants. Of these, 20–30 will be people living with dementia.
Given the potential that both rounds of the Delphi surveys
will be researcher supported, this has resource implica-
tions (e.g. for researchers travelling to and from partici-
pants’ homes across the north-west of England). The
other stakeholder groups will have approximately equal
numbers of participants.
Demographic/other information
All participants who agree to take part in the survey will
be registered with a unique identifier, which will be allo-
cated to enable tracking of attributions at each round.
Upon registration, participants will be asked to identify
themselves with one or more of the stakeholder groups
and provide basic demographic information.
For people living with dementia and care partners, this
includes postcode, gender, ethnicity, religion, living ar-
rangements, current employment status, length of diag-
nosis, and EQ-5D-3L measure (to provide a summary of
health). For health and social care professionals, policy-
makers and researchers this includes ethnicity; age
range; job title and role (and recent project involvement
for researchers); organisation and location; qualifications
and specialisms; how long they have been working in de-
mentia care, services or research; other dementia-related
positions held; and whether they have undertaken any
dementia-specific training in the past three years.
Supporting participation of people living with dementia in
both delphi rounds
Round 1: Postal or researcher-supported survey In
round 1, people living with dementia will have the
choice of completing a postal survey or accessing re-
searcher support to assist completion. However, round 2
will need to be completed with researcher support.
There will be an opportunity at the end of the round 1
survey to add additional outcomes. For postal surveys, a
free text comment box will be available. For surveys
completed with researcher support, based on any con-
versations during the administration of the survey, the
researcher will ask the participant if anything else is im-
portant to them and note anything down as an add-
itional outcome.
Round 2: Researcher-supported survey and binary
choice approach The purpose of round 2 is to expose
participants to the views of others, and ask them to re-
flect to attain areas of consensus. This involves present-
ing other participant groups’ feedback, typically in
graphic form such as bar charts, pie charts and histo-
grams. However, member involvement consultations
with people living with dementia in this study have dem-
onstrated how these feedback mechanisms tend not to
be accessible, particularly for people with visuospatial
impairments.
To include people living with dementia in round 2, re-
searchers will initiate an interview format where partici-
pants will be reminded of their round 1 response. Along
with a paper-based version of the survey, participants
living with dementia will then be verbally presented with
a single participant group response, namely that of
health and social care professionals. This is based on the
rationale that, from the wider COS literature and mem-
ber involvement consultation in this study with people
living with dementia, there tend to be differences of
opinion between service users or patients and health
and social care professionals [22].
There are three permutations to reviewing round 1
scores. First, where there is a clear difference between
the two groups, this is likely to be phrased something
like: ‘The last time you said xxx. Most health and social
care professionals said xxx. Do you want to keep your
answer or do you want to change your mind?’ Second,
where there is more of an even split, this is likely to be
phrased something along like: ‘The last time you said
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xxx. Health and social care professionals couldn’t make
their mind up between xxx and xxx. Do you want to
keep your answer or do you want to change your mind?’
Third, when the majority of health and social care pro-
fessionals views reflect the person’s initial answer, this is
likely to be phrased something like: ‘The last time you
said xxx, and the majority of health and social care pro-
fessionals said the same. Do you want to keep your an-
swer or do you want to change your mind?’
This is another key modification to a more standard
Delphi. This process will be administered by researchers
in a calm and respectful manner. Care will be taken to
emphasise that this does not mean the person with de-
mentia’s initial answer was wrong and that, while there
is no pressure for them to change their mind, they are
being invited to reflect on their initial answer, and
change their mind if they wish to.
Being responsive to individuals Data collection consid-
erations for both rounds will be responsive to the needs
of individual participants. While we are offering the sup-
port of a researcher to go through the Delphi survey
with participants (optional for round 1 and necessary for
round 2), additional considerations might include the
setting in which participants are most comfortable to
complete the Delphi, either in their own home or in a
familiar public place.
Another consideration is to provide the option for par-
ticipants to complete either or both rounds in multiple
sittings, or to allow people to only partially complete
either round. While no set time limits have been placed
on how long it will take for a person living with demen-
tia to go through round 1 or round 2, we will judge what
time is appropriate individually. Important to this is to
recognise when participants are tiring. All the re-
searchers and those who will offer researcher support
have experience of communicating with people living
with dementia.
Unlike other studies, aspects of inclusion and being
responsive to the needs of people living with dementia
mean that partial completion in this study will not be
regarded as non-completion.
Randomising the order of the survey questions
The possibility that some people living with dementia
may not be able or wish to complete all questions has
implications for how the Delphi survey will be con-
ducted. Under the usual Delphi process of presenting
the survey items in the same set order to all participants,
allowing partial completion carries a risk that items
lower down in the list will receive substantially fewer, or
possibly no, responses. To counter this, each participant
will receive the items in an individually randomised
order. In addition, over the time frame of data collection,
sections or items with a lower number of responses will
be identified and prioritised in subsequent randomised
lists, where appropriate. This is an important consider-
ation for accommodating participants living with de-
mentia, and represents a further key modification to the
Delphi method.
Gift as a recognition of participation
Participation in the Delphi survey involves completing
two surveys. Specifically, for people living with dementia,
who may complete one or both surveys in multiple sit-
tings, it is possible that participation may involve an
amount of time for which a recognition of involvement
is appropriate. In this study, people living with dementia
will be offered a £10 voucher for participation in each
round. Participants from other stakeholder groups will
be given a £10 voucher upon completion of round 2.
Analysis
The analysis protocol assumes that sufficient numbers of
stakeholders from each group will respond.
Round 1 Data from the round 1 survey will be analysed
separately for each stakeholder group. For each outcome,
the number of participants who score the outcome and
the distribution of rating scores will be summarised in a
histogram. Additional outcomes listed by participants
will be reviewed and checked by members of the re-
search team to ensure they represent new outcomes. If
there is uncertainty, the study advisory group will be
consulted, and we will also draw on previous categorisa-
tions from outcome workshop materials. All outcomes
will be carried forward to round 2.
Round 2 For each outcome, the number of participants
who score the outcome and the distribution of rating
scores will be summarised together with the number
of participants who scored the outcome in both
rounds. This process will be the subject of substantive
member involvement with people living with demen-
tia to ensure that their active participation is accom-
modated in round 2.
The responses of each stakeholder group will be ana-
lysed and compared within that stakeholder group, and
the percentage agreement will be used to determine the
focus of the final consensus meeting. Each outcome by
stakeholder group will be classified as:
 Consensus in: 70% or more participants scored it as
‘very important’ and less than 15% of participants
scored it as ‘not particularly important’.
 Consensus out: 70% or more participants scored it
as ‘not particularly important’ and less than 15% of
participants scored it as ‘very important’.
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 No consensus: Anything else not included in the
other two categories.
A list of the questions where ‘consensus in’ was met
for one or more stakeholder groups will be presented
and used in the following consensus meeting.
Consensus meeting
While there is no accepted definition of what constitutes
consensus in relation to Delphi approaches [29], it is
widely regarded as good practice to finalise consensus
through one or more consensus meetings [21].
Consensus meeting approaches differ, with one key
distinction being whether to host a single meeting with
representatives from all stakeholder groups or to hold
multiple meetings for representatives of each stakeholder
group [40]. This study will convene a face-to-face con-
sensus meeting with a sample of all Delphi study partici-
pants to discuss and attain agreement on the core
outcomes. The meeting with be facilitated by a specialist
independent chair. The meeting format and structure
will be based on how best to accommodate the needs of
each group, particularly people living with dementia.
Though details will be finalised through research team
meetings, existing consensus meeting approaches will be
reviewed and member involvement consultation will be
used to determine a desirable and workable approach.
By the end of this meeting, we will have identified what
outcomes to measure.
Phase 3: Systematic reviews of outcome measurement
instruments
Relating to the outcomes identified in the COS, we will
identify, or where necessary conduct systematic reviews
to identify and assess, the properties of existing outcome
measures used in research for people living with demen-
tia. Any systematic reviews undertaken will be registered
on PROSPERO.
Measurement properties will be assessed using the
Consensus-based Standards for the Selection of Health
Measurement (COSMIN) checklist [41] and the
COSMIN-COMET guidance. Measures will be assessed
for published evidence of validity, reliability and responsive-
ness [42]. The COSMIN database of systematic reviews will
be searched to check if previous researchers have done this
already for a particular instrument of interest.
Phase 4: Stated preference survey
A stated preference approach will be used to estimate
the relative preferences of each stakeholder group for key
outcomes (domains). A questionnaire (SP-CORE) will be
developed from the results of phases 1–3 and refined by
discussion with participants of the Delphi consensus
meeting group and member involvement meetings. The
latter are particularly important to ensure that the survey
design enables people living with dementia to participate
in the survey. Participants will be asked to take part in a
pilot and the respondents for the pilot version of the
SP-CORE will have the choice of completing a postal
or electronic survey.
Recruitment
In earlier study phases, participants of each stake-
holder group will be invited to complete the stated
preference survey. If interest is expressed, a re-
searcher will contact them through their preferred
method. Information will be provided about the stated
preference survey to ensure that they understand the
survey and have the opportunity to discuss any ques-
tions. Again, a researcher-supported approach to the
inclusion of people living with dementia in phase 4
will be developed in line with participation ap-
proaches from earlier study phases.
Analysis
The stated preference survey will use an orthogonal
main effect design. Responses from the survey will be
analysed using logistic or probit regression analyses as
appropriate. The coefficients for each attribute will indi-
cate the direction of preference for that attribute. Mar-
ginal rates of substitution will be calculated to estimate
the relative utility of the attributes.
The elicited preference data will be used to explore
the relative importance and preference for different out-
comes included in the COS (domains), and to estimate
preference weights that can be used to combine key do-
mains into a single index [42, 43]. This index can be
used to explore the cost-effectiveness of the develop-
ment of a couple-orientated self-management interven-
tion provided at home (part of another work programme
[6] under the Neighbourhoods and Dementia study).
Discussion
A COS represents the minimum outcomes for a research
area. Studies of specific interventions or programmes
will likely supplement the COS with relevant outcomes.
Following on from other COS studies, this study has key
strengths, including substantive qualitative work with
stakeholders as part of a rigorous process of identifying
outcomes, which the core set will be based on. The
stated preference survey will provide information about
the relative importance of the different outcomes. This
will add to the information available for interpretation of
the results of future evaluations for policy and practice.
It is important to acknowledge the sequential and in-
novative nature of this study. This study is the first, to
the best of our knowledge, to be designed to enable the
participation of people living with dementia. This is a
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key strength, made possible by a modified Delphi
process. It was necessary that the design of the modified
Delphi process be influenced by phase 1.1 (qualitative
data collection) and the member involvement consult-
ation in the early part of phase 2. This has resulted in a
Delphi study design responsive enough to accommodate
the participation of people living with dementia.
The first modification to the Delphi study design is the
use of a three-point scale, instead of the regular nine-
point scale. The second modification is to complete
surveys with people living with dementia in an
interview-like format. The third modification is to only
expose people living with dementia to the results of
health and social care professionals (as opposed to all
stakeholder groups) in the second round of the Delphi.
The fourth modification is to randomise Delphi questions
for people living with dementia according to the comple-
tion rates of all Delphi questions. All four modifications
are key strengths of this work and are important develop-
ments in involving people living with dementia in research
in a discipline and field where previous attempts may have
been less thoroughly done, if at all.
Some potential limitations should also be highlighted.
Firstly, data collection has been and is limited to the UK.
Furthermore, given the resources and the need for
researcher-supported data collection, the sample of
people living with dementia is mostly restricted to the
north-west of England (although participants have been,
and will be, from diverse parts of this region). The im-
portance of outcomes may, of course, vary within and
across cultures as well as within and across the perspec-
tive of the different stakeholder groups [38]. It is likely
that further work will be needed when developing out-
comes and statements for an international audience.
Secondly, the use of an online survey tool for all stake-
holders (except people living with dementia) will limit
participation to those who are computer literate.
Thirdly, invariably the Delphi surveys will tend to be
completed by people with mild to moderate dementia.
While we will not gauge the views of people with ad-
vanced dementia in phases 2 and 3, these were gained in
phase 1. Despite this particular limitation, as stated
above, this study does mark progress in the participation
in research of people living with dementia.
This study design and the Delphi method are increas-
ingly being recognised as a robust approach to forming
COSs [20]. This study will capture the views of people liv-
ing with dementia, who, along with the other stakeholders,
will come to a consensus around what outcomes should
be measured in relation to non-pharmacological and
community-based programmes. In doing so, this study
will move closer to providing researchers with outcomes
that are important to people living with dementia and other
key stakeholders, thereby increasing the comparability of
studies evaluating interventions and reducing reporting bias
(Additional file 1).
Trial status
Recruitment to phase 1 and member involvement that
informed the design of phase 2 has been completed. At
the time of submission, phase 2, involving the Delphi
survey, is due to start in autumn 2017. The consensus
meeting will take place shortly after the second round of
the Delphi survey. Recruitment for phase 4 will begin in
the middle part of 2018.
Endnotes
1Care partners is the term selected by involvement
groups in work programme 1 of the Neighbourhoods
and Dementia study to refer to those who look after,
support and care for someone living with dementia, in a
non-professional unpaid capacity. This may be a family
member, friend or neighbour.
Additional file
Additional file 1: Recommended items to address in a clinical trial
protocol and related documents*. (DOC 119 kb)
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